Submission Details
| 510(k) Number | K002294 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 27, 2000 |
| Decision Date | October 02, 2000 |
| Days to Decision | 67 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
K002294 is an FDA 510(k) clearance for the BIOCHECK TESTOSTERONE EIA, MODEL BC-1115, a Radioimmunoassay, Testosterones And Dihydrotestosterone (Class I — General Controls, product code CDZ), submitted by Biocheck, Inc. (Northridge, US). The FDA issued a Cleared decision on October 2, 2000, 67 days after receiving the submission on July 27, 2000. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1680.
| 510(k) Number | K002294 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 27, 2000 |
| Decision Date | October 02, 2000 |
| Days to Decision | 67 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
| Product Code | CDZ — Radioimmunoassay, Testosterones And Dihydrotestosterone |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1680 |